Medical Condition

liver cirrhosis

Total Trials

10

Recruiting Now

10

Trial Phases

Phase 2, Phase 1, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for liver cirrhosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — liver cirrhosis Clinical Trials

How many clinical trials are currently recruiting for liver cirrhosis?

ClinicalMetric currently tracks 10 actively recruiting clinical trials for liver cirrhosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for liver cirrhosis?

liver cirrhosis research spans Phase 1 (1 trial), Phase 2 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a liver cirrhosis clinical trial?

Eligibility criteria for liver cirrhosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

University Hospital, Bonn 1 trial

Centre Hospitalier Universitaire Vaudois 1 trial

Centre Hospitalier Universitaire de Nice 1 trial

Northern Jiangsu People's Hospital 1 trial

University Medical Center Groningen 1 trial

Recruiting Clinical Trials

NCT04578301

Recruiting

Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease

University Hospital, Bonn

View Trial →

NCT05869591 Phase 2

Recruiting

DOAC in Patients with Child a or B Liver Cirrhosis

Centre Hospitalier Universitai...

View Trial →

NCT07201649

Recruiting

Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications

Centre Hospitalier Universitai...

View Trial →

NCT07811687

Recruiting

Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function

Northern Jiangsu People's Hosp...

View Trial →

NCT07585890

Recruiting

Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

Enrollment

10,000 pts

Location

Austria, Belgium, Fr...

Sponsor

University Medical Center Gron...

View Trial →

NCT06767579

Recruiting

Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

Assistance Publique - Hôpitaux...

View Trial →

NCT04874428 Phase 1

Recruiting

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

Insel Gruppe AG, University Ho...

View Trial →

NCT07349654

Recruiting

Underdilated-stent Technique Improves Post-TIPS Encephalopathy

The Second Affiliated Hospital...

View Trial →

NCT04932577 Phase 2, Phase 3

Recruiting

Faecal Microbiota Transplantation for Liver Cirrhosis

Related Conditions

portal hypertension (2) surgery (1) acute on chronic liver failure (1) non cirrhotic portal hypertension (1) hcc hepatocellular carcinoma (1) hypersplenism (1) end stage liver disease esld (1) acute liver failure (1) liver transplantation (1) hepatocellular carcinoma (1) variceal bleeding cirrhosis (1) ascites hepatic (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology